Coronavirus: German company BioNTech says its vaccine is 90% effective
By Reuters
15 November 2020 |
11:01 am
A vaccine jointly developed by German company BioNTech and US firm Pfizer has proven to be 90% effective at preventing COVID-19 infections, according to phase 3 trials.
In this article
Related
25 Jul 2021
Organizers confirmed at least 10 coronavirus cases linked to the Olympics, with the two infected athletes listed as non-Japanese. Meanwhile, German experts expect a fourth wave by autumn. Follow DW for the latest.
27 Jul 2021
After developing a coronavirus vaccine in record time, the German pharmaceutical company aims to start trialing a malaria shot next year using the same breakthrough mRNA technology.
3 Aug 2021
Vaccines from both drugmakers have been approved in the EU for children from 12 to 17 years of age. Elsewhere, Australia continues its battle against the delta variant. Follow DW for the latest.
6 Aug 2021
Even though vaccination rates are speeding in the US, so is the spread of the delta variant — prompting officials to reinstate some COVID restrictions previously lifted.
18 Sep 2021
The Syrian province of Idlib, one of the last remaining rebel strongholds in the country's north, is experiencing a new wave of Covid-19 infections, driven by the more contagious Delta variant. This comes as the regime intensifies bombings in the region, putting local hospitals under even greater pressure. We take a closer look.
20 Sep 2021
The announcement comes as coronavirus cases among children surge in the United States and other parts of the world.
2 Oct 2021
The FDA's limited approval comes weeks after US President Joe Biden's administration announced a sweeping plan that would allow nearly all American adults to get a third shot.
2 Oct 2021
The BioNTech/Pfizer vaccine for 5 to 11 year olds could be approved in the US as early as October. Meanwhile, Australia plans to stop paying workers affected by lockdowns. Follow DW for the latest.
6 Oct 2021
While the European Medicines Agency approved a third dose for people over 18-years-old, the agency said it was up to member states to decide whether to use them.
22 Oct 2021
Russian President Vladimir Putin orders a nationwide week-long paid holiday starting on October 30 to curb Covid infections amid record coronavirus deaths.
25 Oct 2021
BioNTech and Pfizer and said their vaccine is highly effective among children in the 5-11-year age group. Follow DW for the latest.
14 Nov 2021
Younger people have a higher risk of heart inflammation with a Moderna shot, the country's vaccine advisory committee has said. It also advises on the BioNTech-Pfizer vaccine to all pregnant women.
Latest
1 hour ago
US oil company ExxonMobil recorded a net profit of $56 billion last year, beating its previous 2008 record. It benefitted from a surge in prices following the Russian invasion of Ukraine and a cost-cutting drive during the pandemic.
1 hour ago
Getting enough sleep is essential to good health, but millions of people struggle with it. As a result, many of us turn to calming music in the hopes that it will lull us to sleep.
1 hour ago
Australia will replace the portrait of Queen Elizabeth II on its $5 banknote with a new design to reflect and honor the history of its Indigenous culture. King Charles III will feature on Australian coins, though.
1 hour ago
Women in low-income communities in India learn how to use energy efficiently. It’s a win-win for the climate as well as the household budget. For many it is the first time they understand the connection between fossil fuels and global warming.
4 hours ago
Scientists in Brazil are hopeful that a campaign to vaccinate endangered monkeys against yellow fever could save them from extinction. The last outbreak of the disease decimated the population of highly vulnerable golden lion tamarin monkeys.
4 hours ago
For months, European leaders have sought a united response to the US Inflation Reduction Act, or IRA. That plan, announced by the White House last year, favours American-made climate technology through subsidies and tax credits. But EU chiefs say the policy discriminates against Washington's closest partner, Europe.